NHS SCOTLAND
Providing advice about the status of all newly licensed medicines
| Drug Number: | 472/08 |
| Drug Name: | retapamulin (Altargo) |
| Drug Manufacturer: | GlaxoSmithKline |
| BNF Category: | Skin |
| Submission type : | Non submission |
| Date Advice Issued: | 07 April 2008 |
| Indication: | for the short term treatment of the following superficial skin infections: Impetigo and infected small lacerations, abrasions, or sutured wounds. |
There is currently no other SMC advice for this product